跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 331 条关于
“Cosmo NV”
全部
331
临床试验
56
药物
97
机构
51
资讯
127
18天前
Baldness Drugs Emerge as Wall Street's Next Goldmine as Novel Treatments Near Market
去年
Cosmo Pharmaceuticals and Takeda Renew Multi-Year Manufacturing Agreement for Ulcerative Colitis Treatment
去年
Cosmo Pharmaceuticals Announces Strong 2024 Revenue Growth and Pipeline Advancements
去年
Cosmo Pharmaceuticals Reports Progress in Clinical Trials and Strategic Growth in 2024
去年
Cosmo Pharmaceuticals Launches First-in-Class Acne Treatment Winlevi in Southeast Asia
4个月前
Cosmo Completes Phase II Enrollment for Novel Rifamycin Enema in Distal Ulcerative Colitis
2年前
NanoViricides' NV-387 Shows Broad-Spectrum Antiviral Activity Against 'Tripledemic' Viruses and Smallpox in Animal Models
2年前
NanoViricides Develops First-In-Class Broad-Spectrum Antiviral Agent NV-387
去年
NanoViricides' NV-387 Advances to Phase II Clinical Trials for MPox Treatment
去年
NanoViricides Advances NV-387 to Phase II Trials Targeting MPox and Respiratory Infections
第 1 页,共 13 页
上一页
下一页